DH endorses recall of eight products manufactured by Ta Fong Pharmaceutical Co., Ltd. (with photos)

     The Department of Health (DH) today (May 27) endorsed two licensed drug wholesalers, Vast Resources Pharmaceutical Limited (Vast Resources) and Yat Seng Trading Co. (Yat Seng), to recall eight pharmaceutical products from the market for a potential quality issue.

     The eight products are:

1. Urodine F.C. tablets 100mg (registration number: HK-56569);
2. Dicokan tablets 30mg (HK-56102);
3. Toeefon tablets 250mg (HK-56387);
4. Shoren suppositories 12.5mg (HK-60943);
5. Molin tablets 10mg (HK-62483); and
6. Famoster Film Coated tablets 20mg (HK-62850) imported by Vast Resources; and
7. Lincomycin Solution for Injection 300mg/ml (Ta Fong) (HK-61712); and
8. Clindamycin capsules 150mg (HK-64191) imported by Yat Seng.

     "We received notification from Vast Resources and Yat Seng that they had been notified by the Taiwanese manufacturer, Ta Fong Pharmaceutical Co., Ltd. to recall affected batches of these eight products as they had not been properly packed and stored in Taiwan. The DH's investigation is continuing," a spokesman for the DH said.

     The above eight products include six prescription-only medicines, a Part I poison and an over-the-counter medicine used for the treatment of various conditions. According to Vast Resources and Yat Seng, the products have been supplied to private doctors and local pharmacies.

     So far, the DH has not received any adverse reports in connection with the products concerned.

     Vast Resources and Yat Seng have respectively set up hotlines (2539 0991 and 2687 6629) to answer related enquiries. The DH will closely monitor the recall.

     People who have used the above products should consult their healthcare professionals when in doubt.

Ends/Friday, May 27, 2016
Issued at HKT 22:14